N-(bromoacetyl)-3,3-dinitroazetidine

N-(bromoacetyl)-3,3-dinitroazetidine
Trade Name
Orphan Indication Neuroendocrine tumors
USA Market Approval USA
USA Designation Date 2017-06-15 00:00:00
Sponsor EpicentRx, Inc.;4445 Eastgate Mall, Suite 200;San Diego, California, 92121
Related Access Program
Advanced Accelerator Applications – Neuroendocrine Tumors Andrei Iagaru – Other Neuroendocrine Tumors Jonsson Comprehensive Cancer Center – Neuroendocrine Tumors Memorial Sloan Kettering Cancer Center. – Neuroendocrine Tumors